financetom
Business
financetom
/
Business
/
Volvo Cars April sales rise on strong EV demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volvo Cars April sales rise on strong EV demand
May 6, 2024 12:51 AM

COPENHAGEN (Reuters) -Volvo Cars' sales rose 27% in April from a year earlier to 65,838 cars, boosted by demand for electric and hybrid vehicles, the Sweden-based group said on Monday.

Volvo Cars, majority-owned by China's Geely Holding, said in a statement sales of fully electric cars were up 94% and accounted for 26% of all sales globally in the month.

Sales in Europe, Volvo Cars' biggest market, jumped 65% compared to the same period last year, reaching 34,238 cars, with the company's fully electric small SUV, EX30, driving sales, Volvo Cars added.

In the United States, total sales rose 10%, primarily driven by an 89% increase in plug-in hybrid car sales, Volvo Cars said.

Meanwhile, sales in China were down 3% compared to the same period last year.

Shares in the company rose 0.5% by 0723 GMT, outperforming a 0.3% rise in Stockholm's benchmark stock index.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK Unit Says Dovato 'Non-Inferior' to Biktarvy in Phase 4 HIV Study
GSK Unit Says Dovato 'Non-Inferior' to Biktarvy in Phase 4 HIV Study
Jul 23, 2024
12:56 PM EDT, 07/23/2024 (MT Newswires) -- GSK (GSK) said Tuesday that its ViiV Healthcare subsidiary's phase 4 clinical trial showed that the two-drug regimen Dovato has non-inferior efficacy compared with the three-drug regimen Biktarvy in people living with human immunodeficiency virus-1, or HIV-1. The study compared Dovato, or dolutegravir and lamivudine, with the Biktarvy regimen, or bictegravir/emtricitabine/tenofovir alafenamide fumarate,...
Apple likely to release foldable iPhone as early as 2026, the Information reports
Apple likely to release foldable iPhone as early as 2026, the Information reports
Jul 23, 2024
July 23 (Reuters) - Apple ( AAPL ) is likely to introduce its foldable iPhone as early as 2026, the Information reported on Tuesday, that could mark the biggest hardware design revamp for the company's most popular product. The Cupertino, California-based company's plan to release a foldable iPhone could mimic a similar move by Samsung Electronics ( SSNLF ), which...
Apple likely to release foldable iPhone as early as 2026, the Information reports
Apple likely to release foldable iPhone as early as 2026, the Information reports
Jul 23, 2024
(Reuters) - Apple ( AAPL ) is likely to introduce its foldable iPhone as early as 2026, the Information reported on Tuesday, that could mark the biggest hardware design revamp for the company's most popular product. The Cupertino, California-based company's plan to release a foldable iPhone could mimic a similar move by Samsung Electronics ( SSNLF ), which pioneered the...
Why Azitra Stock Is Moving Higher On Tuesday
Why Azitra Stock Is Moving Higher On Tuesday
Jul 23, 2024
Azitra, Inc. ( AZTR ) shares are trading higher after the company announced that the U.S. Patent and Trademark Office granted its patent application regarding the treatment of atopic dermatitis. The Details: The patent, U.S. Patent No. 12,036,248, protects a filaggrin-secreting strain of Staphylococcus epidermidis for the treatment of atopic dermatitis. The goal is to address diseases associated with a filaggrin deficiency,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved